Live feed19:51:49·108dINSIDERFilingPresident and CEO Litton Mark James sold $17,792 worth of shares (2,586 units at $6.88) and converted options into 10,834 shares, increasing direct ownership by 25% to 40,828 units (SEC Form 4)ATHA· Athira Pharma Inc.Health CareOriginal source